Search
Sign In Register
Sign In Register
Home / The Science / The Kidney & Plasma Cell Disorders / AL Amyloidosis

AL Amyloidosis

Amyloid protein produced by abnormal plasma cells damages organs including the kidney

AL amyloidosis is characterised by the deposition of an excess of free light chains (FLCs) in the form of amyloid fibrils. These disrupt the structure and function of organs, including the kidney and heart.

Freelite® serum FLC laboratory tests, in combination with immunofixation of serum and urine, provide an efficient diagnostic screen for AL amyloidosis.

At diagnosis, the majority of patients have an abnormal Freelite® sFLC ratio.

Serum FLCs are an effective marker for monitoring AL amyloidosis, and are recommended by International guidelines.

The Kidney & Plasma Cell Disorders resources

Watch the webinar

Videos

AKI in Multiple Myeloma & Light Chain Deposition Disease

Professor Paul Cockwell discusses Acute Kidney Injury in…

Publication

Treatment of acute renal failure secondary to multiple myeloma with chemotherapy and extended high cut-off hemodialysis

This paper is available to order

Publication

Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure

This paper is available to order